Denali Therapeutics Net Non-Operating Interest Income Expense (Quarterly) Trends

Denali Therapeutics, Inc. (DNLI)

17.63 -0.36 (-2.00%) USD | NASDAQ | Jan 20, 12:26

View Net Non-Operating Interest Income Expense (Quarterly) for DNLI.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Enovis Corp.	Upgrade
Masimo Corp.	Upgrade
Protalix Biotherapeutics, Inc.	Upgrade
Twist Bioscience Corp.	Upgrade
AIM ImmunoTech, Inc.	Upgrade